SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-20-000090
Filing Date
2020-11-12
Accepted
2020-11-12 16:12:06
Documents
32
Period of Report
2020-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axearningsreleaseq32020.htm 8-K 28105
2 EX-99.1 ex991-earningsreleaseq.htm EX-99.1 67122
3 EX-99.2 phasebiocorporateovervie.htm EX-99.2 56242
4 phasebio2020logo1.jpg GRAPHIC 27705
5 GRAPHIC phasebiocorporateovervie001.jpg GRAPHIC 65031
6 GRAPHIC phasebiocorporateovervie002.jpg GRAPHIC 201484
7 GRAPHIC phasebiocorporateovervie003.jpg GRAPHIC 154400
8 GRAPHIC phasebiocorporateovervie004.jpg GRAPHIC 115611
9 GRAPHIC phasebiocorporateovervie005.jpg GRAPHIC 35257
10 GRAPHIC phasebiocorporateovervie006.jpg GRAPHIC 104701
11 GRAPHIC phasebiocorporateovervie007.jpg GRAPHIC 56893
12 GRAPHIC phasebiocorporateovervie008.jpg GRAPHIC 123069
13 GRAPHIC phasebiocorporateovervie009.jpg GRAPHIC 44040
14 GRAPHIC phasebiocorporateovervie010.jpg GRAPHIC 136678
15 GRAPHIC phasebiocorporateovervie011.jpg GRAPHIC 94515
16 GRAPHIC phasebiocorporateovervie012.jpg GRAPHIC 113131
17 GRAPHIC phasebiocorporateovervie013.jpg GRAPHIC 116345
18 GRAPHIC phasebiocorporateovervie014.jpg GRAPHIC 113166
19 GRAPHIC phasebiocorporateovervie015.jpg GRAPHIC 129340
20 GRAPHIC phasebiocorporateovervie016.jpg GRAPHIC 122471
21 GRAPHIC phasebiocorporateovervie017.jpg GRAPHIC 134341
22 GRAPHIC phasebiocorporateovervie018.jpg GRAPHIC 105650
23 GRAPHIC phasebiocorporateovervie019.jpg GRAPHIC 126175
24 GRAPHIC phasebiocorporateovervie020.jpg GRAPHIC 54838
25 GRAPHIC phasebiocorporateovervie021.jpg GRAPHIC 95911
26 GRAPHIC phasebiocorporateovervie022.jpg GRAPHIC 108550
27 GRAPHIC phasebiocorporateovervie023.jpg GRAPHIC 109002
28 GRAPHIC phasebiocorporateovervie024.jpg GRAPHIC 117477
29 GRAPHIC phasebiocorporateovervie025.jpg GRAPHIC 47883
30 GRAPHIC phasebiocorporateovervie026.jpg GRAPHIC 142275
31 GRAPHIC phasebiocorporateovervie027.jpg GRAPHIC 121351
32 GRAPHIC phasebiocorporateovervie028.jpg GRAPHIC 57106
  Complete submission text file 0001169245-20-000090.txt   4253376
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 201306797
SIC: 2834 Pharmaceutical Preparations